| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/09/1998 | WO1998014593A2 Human telomerase catalytic subunit |
| 04/09/1998 | WO1998014592A2 Telomerase reverse transcriptase |
| 04/09/1998 | WO1998014586A1 A polynucleotide herpes virus vaccine |
| 04/09/1998 | WO1998014579A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | WO1998014572A1 Novel human phospholemman-like protein |
| 04/09/1998 | WO1998014568A1 Human growth gene and short stature gene region |
| 04/09/1998 | WO1998014563A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
| 04/09/1998 | WO1998014464A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 04/09/1998 | WO1998014461A1 NOVEL spsB |
| 04/09/1998 | WO1998014456A1 Method for treating cyanide poisoning |
| 04/09/1998 | WO1998014454A2 (o-ACYL-p-N-ACYLAMINO-PHENYL)-O-PHOSPHOETHANOLAMINES |
| 04/09/1998 | WO1998014450A1 Pyrimidine derivatives and processes for the preparation thereof |
| 04/09/1998 | WO1998014447A1 Novel indole-2,3-dione-3-oxime derivatives |
| 04/09/1998 | WO1998014446A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | WO1998014445A2 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | WO1998014444A1 N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics |
| 04/09/1998 | WO1998014436A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 04/09/1998 | WO1998014433A1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 04/09/1998 | WO1998014432A1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives |
| 04/09/1998 | WO1998014431A1 Nitrogenous heterocyclic compounds |
| 04/09/1998 | WO1998014427A1 Nmda (n-methyl-d-aspartate) antagonists |
| 04/09/1998 | WO1998014424A1 Hydroxamic acid derivatives |
| 04/09/1998 | WO1998014237A1 Skin battery cosmetic composition |
| 04/09/1998 | WO1998014215A2 Glycoconjugates as virus cell adhesion inhibitors |
| 04/09/1998 | WO1998014214A1 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (gvhd) and organ transplantation |
| 04/09/1998 | WO1998014200A1 The regulation of appetite, body weight and athletic function with materials derived from citrus varieties |
| 04/09/1998 | WO1998014198A1 Methods and compositions for preventing and treating heartburn |
| 04/09/1998 | WO1998014197A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | WO1998014196A1 Liquid alendronate formulations |
| 04/09/1998 | WO1998014195A1 Use of vitamin d analogs for the treatment of arthritic disease |
| 04/09/1998 | WO1998014194A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of anxiety |
| 04/09/1998 | WO1998014193A1 The use of a substance p antagonist for the manufacture of a medicament for the treatment of ocular pain |
| 04/09/1998 | WO1998014192A1 Vitronectin receptor antagonists |
| 04/09/1998 | WO1998014191A1 Agent for inhibition of cytokine production and agent for inhibition of cell adhesion |
| 04/09/1998 | WO1998014190A1 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 04/09/1998 | WO1998014189A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| 04/09/1998 | WO1998014188A1 Dfmo and taxol for the treatment or prevention of breast cancer |
| 04/09/1998 | WO1998014186A1 Substances and their uses |
| 04/09/1998 | WO1998014184A1 Patch |
| 04/09/1998 | WO1998014183A1 Trans-sodium crocetinate, methods of making and methods of use thereof |
| 04/09/1998 | WO1998014182A1 Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| 04/09/1998 | WO1998014181A1 Treatment and prevention of hepatic disorders |
| 04/09/1998 | WO1998014179A1 Taste-masked microcapsule compositions and methods of manufacture |
| 04/09/1998 | WO1998014174A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 04/09/1998 | WO1998014173A1 Edible, low calorie compostions of a carrier and an active ingredient and methods for preparation thereof |
| 04/09/1998 | WO1998014172A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 04/09/1998 | WO1998014168A2 Dosage form providing a sustained and ascending drug release |
| 04/09/1998 | WO1998014162A1 Agent for acting upon the organism |
| 04/09/1998 | WO1998006435A3 COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA) |
| 04/09/1998 | WO1998002145A3 β-LACTAM GRANULES FREE OF ORGANIC SOLVENTS |
| 04/09/1998 | WO1998001549A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 04/09/1998 | WO1998001546A3 Polyketides and their synthesis |
| 04/09/1998 | WO1998001156A3 Method for producing chlorins and bacteriochlorins containing polyether |
| 04/09/1998 | WO1997045746A3 Prion protein binding proteins and uses thereof |
| 04/09/1998 | WO1997045550A3 Mini-adenoviral vector |
| 04/09/1998 | WO1997039721A3 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 04/09/1998 | DE19701141C1 Gene construct for treatment of disease involving protease, particularly tumours and inflammation |
| 04/09/1998 | DE19641437A1 1,3-Bis-(N-lactamyl)propane und deren pharmazeutische und kosmetische Verwendung 1,3-bis (N-lactamyl) propane and its pharmaceutical and cosmetic use |
| 04/09/1998 | DE19637518A1 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung PTX-sensitive G-proteins, their production and use |
| 04/09/1998 | CA2647169A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2645721A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2555678A1 Hydrophilic microparticles and methods to prepare same |
| 04/09/1998 | CA2515884A1 Dosage form and method for administering drug |
| 04/09/1998 | CA2269079A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | CA2268953A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 04/09/1998 | CA2268114A1 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | CA2267950A1 (o-acyl-p-n-acylamino-phenyl)-o-phosphoethanolamines |
| 04/09/1998 | CA2267694A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | CA2267664A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2267645A1 A polynucleotide herpes virus vaccine |
| 04/09/1998 | CA2267415A1 Hydroxamic acid derivatives |
| 04/09/1998 | CA2267412A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | CA2267370A1 Liquid alendronate formulations |
| 04/09/1998 | CA2267248A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| 04/09/1998 | CA2267097A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2266752A1 Telomerase reverse transcriptase |
| 04/09/1998 | CA2266510A1 N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics |
| 04/09/1998 | CA2265558A1 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 04/09/1998 | CA2265449A1 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | CA2265447A1 Novel human phospholemman-like protein |
| 04/09/1998 | CA2264524A1 Patch |
| 04/09/1998 | CA2217846A1 A combination preparation containing tramadol and a calcium channel antagonist |
| 04/08/1998 | EP0834517A1 Novel anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-mannopyranosyl group |
| 04/08/1998 | EP0834510A2 Flavone derivative and medicine comprising the same |
| 04/08/1998 | EP0834508A1 Substituted biphenyl or phenylpyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/08/1998 | EP0834507A1 Substituted diamino-1,3,5-triazine derivatives |
| 04/08/1998 | EP0834317A1 Ameliorant for pruritus cutaneous accompanying renal failure |
| 04/08/1998 | EP0834316A1 Use of sulbutiamine for the treatment of psychomotor or psycho-intellectual problems |
| 04/08/1998 | EP0834315A1 Use of an imidazole derivative for the manufacture of a medicament for preventing and/or treating rhinitis |
| 04/08/1998 | EP0834314A1 Granules containing pranlukast, process for producing the granules, and method of lowering cohesiveness of pranlukast |
| 04/08/1998 | EP0834313A1 Therapeutic treatment for central nervous system diseases associated with HIV infection |
| 04/08/1998 | EP0834312A1 Topical medicament containing diclofenac |
| 04/08/1998 | EP0834311A1 Method for inhibiting the growth of mammalian cells |
| 04/08/1998 | EP0834310A1 Use of adamantin-derivatives for the treatment of internal-ear-diseases |
| 04/08/1998 | EP0834308A1 Ophthalmic formulation for treating myopia comprising dopamine agonist and cyclodextrin |
| 04/08/1998 | EP0834262A1 Substance containing health-promoting component and process for the production thereof |
| 04/08/1998 | EP0833948A1 Colon specific gene and protein |
| 04/08/1998 | EP0833916A1 Decorin binding protein compositions and methods of use |
| 04/08/1998 | EP0833913A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 04/08/1998 | EP0833909A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines |